is proud to present our monthly webinar series: hot topics in tobacco cessation & secondhand...
TRANSCRIPT
Is Proud to Present our Monthly Webinar Series:
Hot Topics in Tobacco Cessation & Secondhand Smoke Exposure
Reduction
Tuesday, February 5, 2008 12- 1 pm MT
GoToMeeting: https://www1.gotomeeting.com/register/136586400 Call-in #: 888-305-2039 passcode: 74375#
If you have any technical difficulties, please call 720-297-1681.
Presented by Elizabeth Kraft, MD, MHS with support from:
www.coloradoguidelines.org/tobacco
2
Smoking Cessation/Secondhand Smoke Guideline:
1. ASK ADVISE REFER
CCGC is your resource for tobacco information:2. www.coloradoguidelines.org/tobacco
Integrate tobacco cessation into your practice:3. Call CCGC to schedule a TRIA
Call Emma at 303/962-8992 or
email [email protected]
3 Things to Remember:
www.coloradoguidelines.org/tobacco
3
1. CCGC/Tobacco Program:
• Tobacco Cessation and Secondhand Smoke Exposure Guideline: ASK ADVISE and REFER
• CCGC tobacco resources
2. Practice redesign: TRIA
3. Hot Topics:
• Pharmacotherapy update
• PREP and SNUS
• Nicotine Vaccine
• Recruiting for a prenatal tobacco committee
4. Upcoming Webinars
Objectives
www.coloradoguidelines.org/tobacco
4
1. Clinical Guidelines:• Diabetes• Depression• Screening for Colorectal Cancer• Asthma• Pediatric and Adult Immunizations• Upper Respiratory Infections• Gestational Diabetes• Obesity• CV/Stroke • Tobacco Cessation and Secondhand Smoke Exposure
Colorado Clinical Guidelines Collaborative (CCGC)
2. Lead Agency for provider education and resource for tobacco cessation
3. Home for a national pilot called IPIP to Improve Performance In primary care Practices
A coalition of health plans, physicians, hospitals, employers and other entities working together to
implement systems and use evidence-based guidelines to improve healthcare in Colorado.
www.coloradoguidelines.org720/297-1681
www.coloradoguidelines.org/tobacco
5
Tobacco Use in CO
17.3% of Coloradans use Tobacco
www.coloradoguidelines.org/tobacco
6
The 5As Intervention Model Works
www.coloradoguidelines.org/tobacco
7
2A/1R: ASK ADVISE REFER
www.coloradoguidelines.org/tobacco
8
1.800.QUIT.NOW
1.800.784.8669
www.coquitline.org
March 4 12 – 1 MTWebinar on QuitLine: What Colorado Physicians Need to Know
About QuitLine
•7 days/week
•Free coaching
•Free NRT patches x 1 month
•English, Spanish
•Special protocols for teens, pregnancy, smokeless
www.coloradoguidelines.org/tobacco
9
Have Tools Readily Available
Order free supplies at:
www.steppitems.com
www.coloradoguidelines.org/tobacco
10
www.coloradoguidelines.org/tobaccoA Resource for You
•Webinar recordings
•Calendar of events
•Training request forms
•Current research
•Funding opportunities
•Professional development
www.coloradoguidelines.org/tobacco
11
Question: How Can I Do a Better Job of Tobacco Cessation in My Practice?
“Insanity: Doing the same thing over and over again and expecting different results.”
-Albert Einstein
www.coloradoguidelines.org/tobacco
12
Tobacco Cessation
Obesity
Diabetes
Apply these systems changes to other chronic conditions
Answer: Practice redesign with tobacco cessation guideline integration as the
process
www.coloradoguidelines.org/tobacco
13
•Process:•Use the tobacco cessation/SHS guideline: 2A/1R•Lunch session with entire office staff: “TRIA” exercise•Why tobacco cessation is important for your practice•Brainstorm implementation goals for each team staff member•Make changes after each patient
Integrate Tobacco Cessation into YOUR Office:
Tobacco Rapid Improvement Activity (TRIA)
Tobacco Rapid Improvement Activity:
Integrating Tobacco Cessation
into Your Clinical Practice
You Can Be the Difference!
www.coloradoguidelines.org/tobacco
14
http://www.coloradoguidelines.org/tobacco/tria.asp
View a video simulation of aTobacco Rapid Improvement Activity (TRIA)
www.coloradoguidelines.org/tobacco
15
What really works, how do we prescribe, and what should we be looking for? What is the buzz about Chantix?
It is recommended by the national PHS guideline to offer pharmacotherapy support, if there are no contraindications, as integral to tobacco cessation efforts.
Hot Topic: Pharmacotherapy
May 20 12 – 1 MTWebinar: Pharmacotherapy for Tobacco Cessation: Treatment Update & Clinical Pearls
www.coloradoguidelines.org/tobacco
16
Pharmacotherapy
•Doubles cessation rates•Can use >1 NRT•Additive therapies •Long term usage•Tailor to your patient
www.coloradoguidelines.org/tobacco
17
% Quit Rates at 6 Months
Am Fam Phys July 2006 page 263; JAMA July 2006
0
10
20
30
40
50
60
MD b
rief
tele
self-
help
patc
hsp
ray
bupr
oprio
n SR
patc
h +
gum
patc
h +
Spray
patc
h +
bupr
oprio
n
QuitL
ine +
pat
ch
Chant
ix (a
t 3 m
o)
www.coloradoguidelines.org/tobacco
18
Recent Headlines
• “Is Stopping Smoking a Suicide Risk?”
• “Chantix Suicidal Ideation Reports Doubled in 2 Months”
• “Girlfriend Believes Chantix contributed to Texas Musician’s Death”
www.coloradoguidelines.org/tobacco
19
Chantix: Update• Chantix pharmacology:
Selective nicotinic 4 β2 receptor partial agonist. Results in 30% less DA release than nicotine (lower craving) + antagonistic action that blocks reward properties (decrease satisfaction)
• Chantix labeling update: In January 2008, the CHANTIX product insert was updated to
include a warning that patients who are attempting to quit smoking with CHANTIX should be observed for serious neuropsychiatric symptoms, including changes in behavior, agitation, depressed mood, suicidal ideation and suicidal behavior.
• What should I be doing with this new information? Observe all patients, including Chantix patients, for potential
neuropsychiatric symptoms while trying to quit. Monitor frequently. Discuss risks of smoking, benefits of quitting, withdrawal symptoms, strategies to deal with withdrawal, support options (such as the QuitLine), & other pharmacotherapy options.
www.coloradoguidelines.org/tobacco
20
Hot Topic: SNUS/SLT/PREP- the Next Generation of Tobacco
Products• What is PREP, SLT and SNUS?
•PREP = potentially reduced exposure products (SNUS, snuff, lozenges)•SNUS = “snuff” in Sweden; fine moist pasteurized smokeless spitless tobacco; teabag-like pouches;•SLT = smokeless tobacco
www.coloradoguidelines.org/tobacco
21
Harm Reduction vs. Exposure Reduction
• Harm reduction – reduction in amount of tobacco related morbidity and mortality even with continued exposure to tobacco-related toxicants
• Exposure reduction- intervention designed to lessen intake of tobacco delivered toxicants
• National Guideline does not support harm reduction
• FDA does not regulate toxicant levels (as in Sweden) in SLT
• Data not clear and conflicting
• Nicotine still addictive
• SLT toxicants still harmful: Pancreatic cancer, metabolic effects (metabolic syndrome, fetal toxicity, unclear cardiac) & oral pathology
www.coloradoguidelines.org/tobacco
22
Hot Topic: Nicotine Vaccine
• Nicotine is not immunogenic• Vaccine makes antibodies against nicotine• Antibody is a large protein that binds to nicotine,
making it unable to reach brain• Linked to a viral base particle that will give mild
viral syndrome (70%)
• Currently, 3 vaccines being tested:– NABI - 2 vaccinations with 2 boosters 25% stop smoking– TA-Nic- good efficacy (25% at 1 year); phase 3 – CYTOS – lots of side effects, phase 2, 9% improvement
vs. placebo
www.coloradoguidelines.org/tobacco
23
Prenatal Tobacco Advisory Committee
• Prenatal tobacco use one of top reasons for low birth weight
• CCGC tobacco team is putting together an advisory committee
• If you have an interest or know of a provider who might be interested, please contact Emma at CCGC:
303/962-8992 or
www.coloradoguidelines.org/tobacco
24
National Tobacco Guideline
• First update since 2000
• Will update 11 specific areas with evidence-based information
• CCGC asked to be a peer reviewer
• Anticipate release this Spring
www.coloradoguidelines.org/tobacco
25
CCGC Tobacco Webinars:Mark Your Calendar
All webinars from 12-1 pm
– Mar. 4, 2008: What Colorado Physicians Need to Know about the QuitLine, presented by Dr. David Tinkelman
– Mar. 18, 2008: Clinical Practice Grant Opportunities
– Apr. 1, 2008: Tobacco Cessation for Persons with Mental Illnesses: Primary Care Strategies, presented by Drs. Jeanette Waxmonsky & Alexis Giese
– Apr. 15, 2008: Stages of Change & Motivational Interviewing with Clinical Populations, presented by Dr. Heather LaChance
– May 20, 2008: Pharmacotherapy for Tobacco Cessation: Treatment Update and Clinical Pearls, presented by Laura Hansen, RPA
– For more information on each webinar visit
www.coloradoguidelines.org/tobacco and click on “Professional Development.”
Visit:www.coloradoguidelines.org/tobacco
Questions? [email protected]
For a TRIA, contact:
Emma at 303/962-8992 or
28
www.coloradoguidelines.org/tobacco
27
Thank you for your time